Production (Stage)
Advanced BioMedical Technologies, Inc.
ABMT
$0.0001
-$0.0003-75.00%
OTC PK
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 50.41% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.41% | -- | -- | -- | -- |
| Cost of Revenue | -32.13% | -- | -- | -- | -- |
| Gross Profit | 159.37% | -- | -- | -- | -- |
| SG&A Expenses | 51.74% | -- | -- | -- | -- |
| Depreciation & Amortization | -0.80% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.40% | -- | -- | -- | -- |
| Operating Income | 14.76% | -- | -- | -- | -- |
| Income Before Tax | -3.68% | -- | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.68% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.68% | -- | -- | -- | -- |
| EBIT | 14.76% | -- | -- | -- | -- |
| EBITDA | 14.71% | -- | -- | -- | -- |
| EPS Basic | -2.88% | -- | -- | -- | -- |
| Normalized Basic EPS | -3.08% | -- | -- | -- | -- |
| EPS Diluted | -57.35% | -- | -- | -- | -- |
| Normalized Diluted EPS | -3.08% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 0.44% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 0.50% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |